TNF Pharmaceuticals, Inc.
4 clinical trials · Sponsor
◉ Watch TNF Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures (NCT06942182) | TNF Pharmaceuticals, Inc. | 2025-05-01 |
| Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty (NCT05283486) | TNF Pharmaceuticals, Inc. | 2022-02-01 |
| Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects (NCT05077865) | TNF Pharmaceuticals, Inc. | 2021-04-26 |
| Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects (NCT04349761) | TNF Pharmaceuticals, Inc. | 2019-06-11 |
Track TNF Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.